Titan Pharmaceuticals (TTNP) Competitors $4.58 +0.02 (+0.44%) As of 09:53 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock TTNP vs. ALVR, PMN, RLYB, CLRB, BFRG, GELS, HOTH, NKGN, IBIO, and ABPShould you be buying Titan Pharmaceuticals stock or one of its competitors? The main competitors of Titan Pharmaceuticals include AlloVir (ALVR), ProMIS Neurosciences (PMN), Rallybio (RLYB), Cellectar Biosciences (CLRB), Bullfrog AI (BFRG), Gelteq (GELS), Hoth Therapeutics (HOTH), NKGen Biotech (NKGN), iBio (IBIO), and Abpro (ABP). These companies are all part of the "pharmaceutical products" industry. Titan Pharmaceuticals vs. Its Competitors AlloVir ProMIS Neurosciences Rallybio Cellectar Biosciences Bullfrog AI Gelteq Hoth Therapeutics NKGen Biotech iBio Abpro AlloVir (NASDAQ:ALVR) and Titan Pharmaceuticals (NASDAQ:TTNP) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, community ranking, valuation, media sentiment, analyst recommendations, dividends and earnings. Is ALVR or TTNP more profitable? AlloVir's return on equity of -71.03% beat Titan Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets AlloVirN/A -71.03% -61.27% Titan Pharmaceuticals N/A -118.01%-103.79% Do insiders and institutionals believe in ALVR or TTNP? 66.1% of AlloVir shares are owned by institutional investors. Comparatively, 31.5% of Titan Pharmaceuticals shares are owned by institutional investors. 32.1% of AlloVir shares are owned by company insiders. Comparatively, 0.7% of Titan Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community prefer ALVR or TTNP? Titan Pharmaceuticals received 308 more outperform votes than AlloVir when rated by MarketBeat users. However, 57.45% of users gave AlloVir an outperform vote while only 52.84% of users gave Titan Pharmaceuticals an outperform vote. CompanyUnderperformOutperformAlloVirOutperform Votes2757.45% Underperform Votes2042.55% Titan PharmaceuticalsOutperform Votes33552.84% Underperform Votes29947.16% Which has preferable valuation and earnings, ALVR or TTNP? Titan Pharmaceuticals has higher revenue and earnings than AlloVir. Titan Pharmaceuticals is trading at a lower price-to-earnings ratio than AlloVir, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlloVirN/AN/A-$190.42M-$20.23-0.14Titan Pharmaceuticals$180K23.26-$5.57M-$4.59-1.00 Does the media favor ALVR or TTNP? In the previous week, AlloVir and AlloVir both had 2 articles in the media. Titan Pharmaceuticals' average media sentiment score of 1.43 beat AlloVir's score of 0.00 indicating that Titan Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment AlloVir Neutral Titan Pharmaceuticals Positive Which has more risk & volatility, ALVR or TTNP? AlloVir has a beta of 0.63, suggesting that its stock price is 37% less volatile than the S&P 500. Comparatively, Titan Pharmaceuticals has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500. SummaryAlloVir and Titan Pharmaceuticals tied by winning 6 of the 12 factors compared between the two stocks. Get Titan Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TTNP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TTNP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TTNP vs. The Competition Export to ExcelMetricTitan PharmaceuticalsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.19M$3.10B$5.59B$8.59BDividend YieldN/A1.57%5.28%4.18%P/E Ratio-1.0033.2527.1220.00Price / Sales23.26466.71419.48155.53Price / CashN/A168.6838.2534.64Price / Book0.523.437.104.69Net Income-$5.57M-$72.35M$3.23B$247.88M7 Day Performance-6.72%6.51%2.45%2.34%1 Month Performance-12.43%16.87%8.65%6.06%1 Year Performance-34.01%-17.11%31.26%13.59% Titan Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TTNPTitan Pharmaceuticals1.2008 of 5 stars$4.58+0.4%N/A-30.1%$4.19M$180K-1.0010Positive NewsShort Interest ↓ALVRAlloVirN/A$3.30+6.1%N/A-83.2%$16.64MN/A-0.16110PMNProMIS Neurosciences2.3858 of 5 stars$0.51+5.6%$4.50+791.1%-68.7%$16.51MN/A-5.055Gap UpRLYBRallybio3.2192 of 5 stars$0.37-5.1%$10.00+2,568.1%-78.3%$16.44M$848K-0.2340Positive NewsGap DownCLRBCellectar Biosciences2.6221 of 5 stars$0.36-1.6%$12.50+3,421.1%-86.9%$16.36MN/A-0.2110Short Interest ↓Gap UpBFRGBullfrog AI2.0105 of 5 stars$1.71+1.2%N/A-33.2%$16.10M$60K-2.014News CoveragePositive NewsGap UpGELSGelteqN/A$1.70+0.6%N/AN/A$16.05MN/A0.00N/ANews CoverageGap DownHOTHHoth Therapeutics3.2216 of 5 stars$1.19-8.5%$4.00+236.1%+33.6%$15.72MN/A-0.904News CoverageShort Interest ↓NKGNNKGen Biotech0.8519 of 5 stars$0.34flatN/A-76.1%$15.28M$80K-0.07N/AGap DownIBIOiBio1.1959 of 5 stars$0.91-7.1%$4.30+370.2%-61.0%$15.11M$375K0.00100Gap UpHigh Trading VolumeABPAbproN/A$0.25+17.8%$4.00+1,514.2%N/A$15.06M$183K0.0015Positive NewsGap Down Related Companies and Tools Related Companies AlloVir Alternatives ProMIS Neurosciences Alternatives Rallybio Alternatives Cellectar Biosciences Alternatives Bullfrog AI Alternatives Gelteq Alternatives Hoth Therapeutics Alternatives NKGen Biotech Alternatives iBio Alternatives Abpro Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TTNP) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Titan Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Titan Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TTNP Stock Free TTNP Stock Alerts